Probi (Sweden) has announced a research collaboration with the Global BHP BrainTrust and FINGERS Brain Health Institute (FBHI) aimed at reducing dementia risk in women, who account for two-thirds of Alzheimer’s cases. The collaboration is part of the planned FINGERS Plus for Women study.

“We are thrilled to be part of the FINGERS Plus for Women initiative. This collaboration represents a significant step forward in our commitment to advancing brain health and improving everyday life for people worldwide,” said Anita Johansen, CEO of Probi AB. “By combining our expertise in probiotics with the innovative research approach of the Global BHP BrainTrust and the Fingers Brain Health Institute, we aim to make a significant impact on cognitive health and well-being.”

Probi AB and the Global BHP BrainTrust said they are excited to announce the intention to collaborate on the FINGERS Plus for Women initiative together with the FBHI, which was founded in 2019 by Professors Miia Kivipelto and Maris Hartmani. FBHI drives, coordinates and supports the continued clinical research that builds on the original FINGER study, which showed that lifestyle factors have significant relevance in the prevention of cognitive decline.

The goal is to advance and expand the multi-domain FINGER model for preventive lifestyle interventions, exploring new modifiable risk and protective factors such as stress, sleep, education, music, diet and the microbiome. Thus, providing deeper insights into how microbiome intervention, e.g. changes in the body’s ecosystem of microorganisms, along with other protective factors, can collectively influence cognitive function and mental well-being in women.

The initiative is driven by the growing recognition of the critical role that lifestyle factors and the microbiome play in brain health. According to the latest evidence 45 percent of all dementias are likely linked to modifiable risk factors creating great potential for prevention. This research has the potential to deliver transformative impact, including the development of targeted interventions to enhance brain health and prevent cognitive decline. The findings will contribute to a broader understanding of personalized health strategies, ultimately improving the quality of life for women worldwide.

For more information, visit www.probi.com or www.globalbhptrust.com.